Situation Report

nejm.org

A collection of articles and other resources on the Ebola outbreak, including clinical reports, management guidelines, and commentary.

CLICK HERE - NEJM Ebola Outbreak page, where all content is FREE

https://www.facebook.com/TheNewEnglandJournalofMedicine/posts/10152498380218462

Image:  A hydraulic fracturing well in Colorado. With the technology, America is expected to surpass Saudi Arabia in oil production. Credit Brennan Linsley/Associated Press

nytimes.com - November 28th, 2014 - Clifford Krauss

Since the economically crippling oil embargo of 1973, every American president has pledged to seek and achieve energy independence.

That elusive goal may finally have arrived, at least for the foreseeable future, with the failure of Saudi Arabia and its 11 oil cartel partners in the Organization of the Petroleum Exporting Countries to agree to a production cut that would put a brake on plummeting crude prices.

On Friday, the benchmark American price for crude oil continued the free fall that began on Thursday, closing at $66.15, its lowest price in more than four years.

ASSOCIATED PRESS  By MICHELLE FAUL and JAMEY KEATEN Nov. 27, 2014

CONAKRY, Guinea --   ...President Alpha Conde says his government must coordinate the  (expected French)  response, one that aid workers say is confusing and inefficient. Overall the responsibility for the crisis has changed hands several times, from WHO’s regional Africa office, to its headquarters and finally to the U.N. mission.

“It’s difficult for us to understand who is working for (which) WHO” - the local Africa division or the central office in Geneva, said Pascal Piguet, a logistics expert with Doctors Without Borders who leads the Ebola treatment center in the southern town of Gueckedou....

Oyewale Tomori, a professor of virology at Redeemer’s University in Nigeria who sits on WHO’s emergency committee on Ebola, said countries themselves should be coordinating the Ebola control efforts with help from agencies like the U.S. CDC and WHO. “But that’s not happening. We have a very fractured response,” Tomori added....

CNN -- By Laura Smith-Spark                              Nov. 27, 2014

The first human trial of an experimental Ebola vaccine has produced promising results, U.S. scientists said, raising hopes that protection from the deadly disease may be on the horizon.

All 20 healthy adults who received the vaccine in a trial run by researchers from the National Institutes of Health in Maryland produced an immune response and developed anti-Ebola antibodies, the NIH said Wednesday.

None suffered serious side effects, although two people developed a brief fever within a day of vaccination.

The vaccine is being developed by the NIH's National Institute of Allergy and Infectious Diseases and British pharmaceutical giant GlaxoSmithKline. The process has been fast-tracked in light of the current catastrophic Ebola outbreak in West Africa, which has claimed more than 5,000 lives.

http://www.cnn.com/2014/11/27/health/ebola-outbreak/